Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 enero 2012

JOURNAL OF VASCULAR SURGERY. Diabetes is not a predictor of outcome for carotid revascularization with stenting as it may be for carotid endarterectomy

Gianbattista Parlani, MD, Fabio Verzini, MD, PhD, Paola De Rango, MD, PhD, Giuseppe Giordano, MD, Enrico Cieri, MD, PhD, Gioele Simonte, MD, Giacomo Isernia, MD and Piergiorgio Cao, MD, FRCS, Perugia and Rome, Italy

Background: Diabetes is prevalent in most patients undergoing carotid revascularization and is suggested as a marker of poor outcome after carotid endarterectomy (CEA). Data on outcome of diabetic patients undergoing carotid artery stenting (CAS) are limited. The aim of this study was to investigate early and 6-year outcomes of diabetic patients undergoing carotid revascularization with CAS and CEA. Journal of Vascular Surgery Volume 55, Issue 1 , Pages 79-89, January 2012. Copyright © 2012 by the Society for Vascular Surgery.

01 enero 2012

ANNALS OF VASCULAR SURGERY. ViPS (Viabahn Padova Sutureless) Technique: Preliminary Results in the Treatment of Peripheral Arterial Disease

Luca Ferretto , Michele Piazza , Stefano Bonvini, Piero Battocchio , Franco Grego , Joseph J. Ricotta

Background: To describe early results of a novel technique (ViPS, Viabahn Padova Sutureless) that connects a vascular prosthetic graft to a target artery in a sutureless fashion. Annals of Vascular Surgery Volume 26, Issue 1 , Pages 34-39, January 2012. Ann Vasc Surg 2012; 26: 34-39 DOI: 10.1016/j.avsg.2011.07.003 Copiryght © Annals of Vascular Surgery Inc. Published online: October 24, 2011.

01 marzo 2011

SEMINARS IN VASCULAR SURGERY. Treatment of Vertebral Disease: Appropriate Use of Open and Endovascular Techniques

Cheong J. Lee, MD and Mark D. Morasch, MD

Vertebral artery disease is an often underdiagnosed and undertreated cause of posterior circulation ischemia. Revascularization of the vertebral circulation should be considered in patients refractory to medical therapy. Surgical and endovascular techniques are discussed and reviewed in the context of the location and type of vertebral artery disease. Seminars in Vascular Surgery Volume 24, Issue 1 , Pages 24-30, March 2011. Copiryght © 2011 Elsevier Inc. All rights reserved.

01 mayo 2011

JACC: CARDIOVASCULAR INTERVENTIONS. Early and Long-Term Outcomes After Combined Percutaneous Revascularization in Patients With Carotid and Coronary Artery Stenoses

Fabrizio Tomai, MD, Gabriele Pesarini, MD, Fausto Castriota, MD, Bernhard Reimers, MD, Leonardo De Luca, MD, PhD, Giovanni De Persio, MD, Daniela Spartà, MD, Cristina Aurigemma, MD, Andrea Pacchioni, MD, Barbara Spagnolo, MD, Alberto Cremonesi, MD, Flavio Ribichini, MD, FRIENDS (Finalized Research in Endovascular Strategies) Study Group

Objectives: This study sought to evaluate the 30-day and long-term clinical outcomes of patients with carotid obstructive disease (COD) and concomitant coronary artery disease (CAD) undergoing a combined percutaneous revascularization, in 4 high-volume centers skilled for the treatment of multilevel vascular disease. Background: The optimal management of patients with COD and concomitant CAD remains controversial. A variety of therapeutic strategies, including coronary artery bypass grafting, alone or in combination with carotid artery revascularization, have been reported. JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 5, 2011. Copyright © 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00. PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.01.012.

01 junio 2011

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Local Paclitaxel Delivery for Treatment of Peripheral Arterial Disease

Beau M. Hawkins, MD and Thomas A. Hennebry, MB BCh BAO

Local drug delivery is the process by which therapeutic agents are administered to targeted segments of the circulatory system to treat vascular disease. The aims are to optimize therapeutic efficacy by direct drug administration and to minimize untoward effects associated with systemic delivery. This is accomplished in humans with drug-eluting stents (DES), drug-coated balloons (DCB), and direct catheter delivery. Circulation: Cardiovascular Interventions. 2011; 4: 297-302 Published online before print May 3, 2011, doi: 10.1161. Copyright © American Heart Association. All rights reserved. Print ISSN: 1941-7640. Online ISSN: 1941-7632.

01 enero 2012

JOURNAL OF VASCULAR SURGERY. Endovascular retrieval of a TrapEase permanent inferior vena cava filter from the aorta

Sailen G. Naidu, MD, William M. Stone, MD , John P. Sweeney, MD , Samuel R. Money, MD

Intra-aortic inferior vena cava filter placement is a rare event. We describe a case in which a permanent vena caval filter was retrieved from the aorta with endovascular techniques. Knowledge of filter design, catheters, and available wires is important to perform this procedure safely. Journal of Vascular Surgery Volume 55, Issue 1 , Pages 237-239, January 2012. Copyright © 2012 by the Society for Vascular Surgery.

01 marzo 2011

SEMINARS IN VASCULAR SURGERY. Carotid Endarterectomy: Still the Standard of Care for Carotid Bifurcation Disease

Caron Rockman, MD and Shang Loh, MD

Current treatment guidelines of symptomatic and asymptomatic carotid stenosis are based on studies performed over a decade ago. Since that time, significant advances have been made in medical management, namely high dose statin therapy and improved antiplatelet agents, and in carotid interventions, namely the advent of carotid artery stenting. Especially with carotid stenting, the technology has grown by leaps and bounds and continues to advance at a rapid pace. These advances have necessitated new studies to compare these treatments with the gold standard of carotid endarterectomy. In asymptomatic patients, the current data does not justify medical management alone for severe (>80%) carotid stenosis. Furthermore, in both asymptomatic and symptomatic patients current studies have failed to demonstrate equivalence of CAS to CEA for significant carotid stenosis. Clearly additional studies comparing CAS, CEA, and medical management are needed to further clarify this issue. In the future, advances in CAS technology and techniques may greatly expand the role of CAS beyond its current role in certain high-risk patient subsets. However, for the time being CEA still remains the gold standard for carotid intervention. Seminars in Vascular Surgery Volume 24, Issue 1 , Pages 10-20, March 2011. Copiryght © 2011 Elsevier Inc. All rights reserved.

24 mayo 2012

JOURNAL OF VASCULAR SURGERY. Transcervical carotid stenting with flow reversal is a safe technique for high-risk patients older than 70 years

Beatriz Alvarez, MD, PhD, Manuel Matas, MD, PhD, Marc Ribo, MD, PhD, Jordi Maeso, MD, Xavier Yugueros, MD, and Jose Alvarez-Sabin, MD, PhD, Barcelona, Spain

Recent evidence regarding carotid revascularization advises against carotid angioplasty and stenting (CAS) in patients aged >70 years with conventional risk for carotid endarterectomy (CEA). The poor outcome of transfemoral CAS in this age group may be explained by the anatomic characteristics of the aortic trunk and supra-aortic vessels in elderly patients, as well as by a high prevalence of aortic arch atheromatosis. Transcervical CAS with flow reversal for cerebral protection avoids these unfavorable characteristics. This study analyzed the short-term and middle-term results of transcervical CAS with flow reversal in patients aged >70 years at high risk for CEA. Copyright © 2012 by the Society for Vascular Surgery. JOURNAL OF VASCULAR SURGERY Volume 55, Number 4. April 2012

01 enero 2012

JOURNAL OF VASCULAR SURGERY. Long-term follow-up of type II endoleak embolization reveals the need for close surveillance

Timur P. Sarac, MD, Connor Gibbons , Lina Vargas, MD , Jane Liu, MD , Sunita Srivastava, MD , James Bena, MS , Tara Mastracci, MD , Vikram S. Kashyap, MD , Daniel Clair, MD

Aneurysm growth after endovascular aneurysm repair (EVAR) in patients with type II endoleak is associated with adverse outcomes. This study evaluated the long-term success of embolization of type II endoleaks in preventing aneurysm sac growth. Journal of Vascular Surgery Volume 55, Issue 1 , Pages 33-40, January 2012. Copyright © 2012 by the Society for Vascular Surgery.

01 enero 2012

JOURNAL OF VASCULAR SURGERY. Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia

Makoto Utsunomiya, MD, Masato Nakamura, MD , Mami Nakanishi, MD , Takurou Takagi, MD , Hidehiko Hara, MD , Kiyoshi Onishi, MD , Tetsuro Yamada, MD , Kaoru Sugi, MD

Several reports have been published of the acceptable patency and limb salvage rates after infrapopliteal interventions for the treatment of critical limb ischemia (CLI). However, the optimal angiographic end point of endovascular therapy (EVT) remains unclear. This study assessed the relationship between the appearance of wound blush as an angiographic end point and the limb salvage rate in patients with CLI. Journal of Vascular Surgery Volume 55, Issue 1 , Pages 113-121, January 2012. Copyright © 2012 by the Society for Vascular Surgery.

01 enero 2012

JOURNAL OF VASCULAR SURGERY. Presentation, complications, and natural history of penetrating atherosclerotic ulcer disease

Derek P. Nathan, MD , William Boonn, MD , Eric Lai, BS , Grace J. Wang, MD , Nimesh Desai, MD , Edward Y. Woo, MD , Ronald M. Fairman, MD , Benjamin M. Jackson, MD

Objectives: Increased utilization of computed tomography angiography (CTA) has increased the radiologic diagnosis of penetrating atherosclerotic ulcers (PAUs), which are defined as the ulceration of atherosclerotic plaque through the internal elastic lamina into the aortic media. However, the presentation, treatment indications, and natural history of this disease process remain unclear. Journal of Vascular Surgery Volume 55, Issue 1 , Pages 10-15, January 2012. Copyright © 2012 by the Society for Vascular Surgery.

01 enero 2012

JOURNAL OF VASCULAR SURGERY. Diagnosis and treatment of venous lymphedema

Seshadri Raju, MD, James Brooke Furrh, IV, BS, and Peter Neglén, MD, PhD, Flowood, Miss

Chronic venous disease (CVD) is a common cause of secondary lymphedema. Venous lymphedema is sometimes misdiagnosed as primary lymphedema and does not receive optimal treatment. We have routinely used intravascular ultrasound (IVUS) imaging in all cases of limb swelling. The aim of this study is to show that (1) routine use of IVUS can detect venous obstruction missed by traditional venous testing, and (2) iliac-caval venous stenting can yield satisfactory clinical relief and can sometimes reverse abnormal lymphangiographic findings. Journal of Vascular Surgery Volume 55, Issue 1 , Pages 141-149, January 2012. Copyright © 2012 by the Society for Vascular Surgery.

27 septiembre 2011

CIRCULATION. Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease Twelve-Month Zilver PTX Randomized Study Results

Michael D. Dake, MD, Gary M. Ansel, MD, Michael R. Jaff, DO, Takao Ohki, MD, Richard R. Saxon, MD, H. Bob Smouse, MD, Thomas Zeller, MD, Gary S. Roubin, MD, Mark W. Burket, MD, Yazan Khatib, MD, Scott A. Snyder, PhD, Anthony O. Ragheb, PhD, J. King White, MD and Lindsay S. Machan, MD on behalf of the Zilver PTX Investigators

Background —Sustained benefits of drug-eluting stents in femoropopliteal arteries have not been demonstrated. This prospective, multinational, randomized study was designed to compare the 12-month safety and effectiveness of a polymer-free, paclitaxel-coated nitinol drug-eluting stent (DES) with percutaneous transluminal angioplasty (PTA) and provisional bare metal stent (BMS) placement in patients with femoropopliteal peripheral artery disease. Copyright © 2011 American Heart Association. All rights reserved. Print ISSN: 1941-7640. Online ISSN: 1941-7632

01 enero 2012

JOURNAL OF VASCULAR SURGERY. Gender-related outcomes in the endovascular treatment of infrainguinal arterial obstructive disease

Raffaele Pulli, MD , Walter Dorigo, MDemail address , Giovanni Pratesi, MD , Aaron Fargion, MD , Domenico Angiletta, MD , Carlo Pratesi, MD

Objective: The purpose of this study was to retrospectively analyze early and midterm results of endovascular infrainguinal peripheral revascularizations in female patients in our single-center experience, paying particular attention to clinical, anatomic, and technical factors affecting perioperative and follow-up outcomes. Journal of Vascular Surgery Volume 55, Issue 1 , Pages 105-112, January 2012. Copyright © 2012 by the Society for Vascular Surgery.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.